Diabetes mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: Metformin (Najo pharmaceutical co.)and prescribing 500 mg Portulaca Oleracea tablets made in the laboratory of Mashhad School of Pharmacy once a day For three month
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 55 Years
Inclusion criteria
Inclusion criteria: Taking a single drug with metformin less than 2 grams per day HgA1C: 7-9
Exclusion criteria
Exclusion criteria: Pregnancy Complications of Diabetes Immunosuppressants drug and rheumatic inflammatory diseases such as lupus Cardiovascular Disease Hypo or hyperthyroidism Pheochromocytoma, Adrenal insufficiency, Cushing orAcromegaly Kidney failure (GFR <45) Smoking, alcohol, drug abuse Hepatitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fast Blood Sugar. Timepoint: At the beginning of the study and every month. Method of measurement: Blood test.;Hgb A1C. Timepoint: At the beginning of the study and the end of 3end month. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change AtheroSclerotic CardioVascular Disease (ASCVD) risk. Timepoint: Beginning of study and end of 3 months. Method of measurement: ASCVD Risk Estimator - American College of Cardiology.;Lipid profile. Timepoint: At the beginning and end of the study. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Zhahra HabibianNejad
Mashhad University of Medical Sciences
Outcome results
None listed